FDA Drug recall D-0094-2024
Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087
- FDA Drug
- Class III
- ongoing
- Published 2023-11-15
On 2023-11-15 the FDA classified a Class III recall of Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087 by Zyla Life Sciences Us, citing sub-potent Drug: Lower potency than labeled.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0094-2024 |
| Classification | Class III |
| Status | ongoing |
| Initiated | 2023-10-20 |
| Published | 2023-11-15 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Zyla Life Sciences Us |
| Distribution | US |
Product
Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087. NDC: 69344-213-11
Reason
Sub-potent Drug: Lower potency than labeled.
Identifiers
| ndc | 69344-113-11 |
|---|---|
| ndc | 69344-213-11 |
| code_info | Lot 22W02, Exp 01/31/2025 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0094-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.